Send to

Choose Destination
See comment in PubMed Commons below
Int J Pediatr Otorhinolaryngol. 2017 Feb;93:103-106. doi: 10.1016/j.ijporl.2016.12.035. Epub 2016 Dec 27.

Therapeutic use of the HPV vaccine in Recurrent Respiratory Papillomatosis: A case report.

Author information

  • 1Albany Medical College, Albany, NY, USA. Electronic address:
  • 2Division of Otolaryngology and Head-Neck Surgery, Department of Surgery, Albany Medical Center, Albany, NY, USA.


Recurrent Respiratory Papillomatosis (RRP) is a condition characterized by recurring squamous papillomas in the aerodigestive tract due to Human Papilloma Virus (HPV) infection. Treatment includes surgical debridement of the lesions often with adjuvant therapy. A newer adjuvant agent being tested is the HPV vaccine. The case report includes a child with RRP who underwent 10 surgeries in a year with an average inter-surgical interval (ISI) of 46 days. The patient then received the scheduled regimen of 3 doses of 9 valent HPV vaccine. Since beginning the vaccination, her average ISI increased to 113 days and as of writing of this paper only 1 surgery in the last 340 days. It is theorized that the increase in humoral response to the virus can slow the course of the disease, lengthen the ISI, and decrease morbidity. The results of this case report lends evidence to the use of the HPV vaccine as a therapeutic adjuvant therapy for RRP.


HPV; Laryngeal; Papillomatosis; Recurrent; Vaccine

[PubMed - in process]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center